Literature DB >> 30913928

Comparative financing analysis and political economy of noncommunicable diseases.

Mihajlo Jakovljevic1, Melitta Jakab2, Ulf Gerdtham3, David McDaid4, Seiritsu Ogura5, Elena Varavikova6, Joav Merrick7, Roza Adany8, Albert Okunade9, Thomas E Getzen10.   

Abstract

The pandemic of chronic non-communicable diseases (NCDs) poses substantial challenges to the health financing sustainability in high-income and low/middle income countries (LMICs). The aim of this review is to identify the bottle neck inefficiencies in NCDs attributable spending and propose sustainable health financing solutions. The World Health Organization (WHO) introduced the "best buy" concept to scale up the core intervention package against NCDs targeted for LMICs. Population- and individual-based NCD best buy interventions are projected at US$170 billion over 2011-2025. Appropriately designed health financing arrangements can be powerful enablers to scale up the NCD best buys. Rapidly developing emerging nations dominate the landscape of LMICs. Their capability and willingness to invest resources for eradicating NCDs could strengthen WHO outreach efforts in Asia, Africa, and Latin America, much beyond current capacities. There has been a declining trend in international donor aid intended to cope with NCDs over the past decade. There is also a serious misalignment of these resources with the actual needs of recipient countries. Globally, the momentum towards the financing of intersectoral actions is growing, and this presents a cost-effective solution. A budget discrepancy of 10:1 in WHO and multilateral agencies remains in donor aid in favour of communicable diseases compared to NCDs. LMICs are likely to remain a bottleneck of NCDs imposed financing sustainability challenge in the long-run. Catastrophic household health expenditure from out of pocket spending on NCDs could plunge almost 150 million people into poverty worldwide. This epidemiological burden coupled with population ageing presents an exceptionally serious sustainability challenge, even among the richest countries which are members of the Organization for Economic Co-operation and Development (OECD). Strategic and political leadership of WHO and multilateral agencies would likely play essential roles in the struggle that has just begun.

Entities:  

Keywords:  BRICS; EM7; I11; I15; I18; Non-communicable diseases; chronic disease; emerging markets; health financing; low- and middle-income countries; sustainability

Mesh:

Year:  2019        PMID: 30913928     DOI: 10.1080/13696998.2019.1600523

Source DB:  PubMed          Journal:  J Med Econ        ISSN: 1369-6998            Impact factor:   2.448


  53 in total

1.  The Impact of COVID-19 on Non-Communicable Diseases.

Authors:  Abraham Haileamlak
Journal:  Ethiop J Health Sci       Date:  2022-01

2.  Out-Of-Pocket Expenditure Associated with Physical Inactivity, Excessive Weight, and Obesity in China: Quantile Regression Approach.

Authors:  Yang Zhao; Li He; Tiara Marthias; Marie Ishida; Kanya Anindya; Allissa Desloge; Monique D'Souza; Gaofang Cao; John Tayu Lee
Journal:  Obes Facts       Date:  2022-03-04       Impact factor: 4.807

3.  Health systems efficiency in Eastern Mediterranean Region: a data envelopment analysis.

Authors:  Hamed Seddighi; Farhad Nosrati Nejad; Mehdi Basakha
Journal:  Cost Eff Resour Alloc       Date:  2020-07-13

4.  Economic evaluation of remdesivir for the treatment of severe COVID-19 patients in China under different scenarios.

Authors:  Yawen Jiang; Dan Cai; Daqin Chen; Shan Jiang; Lei Si; Jing Wu
Journal:  Br J Clin Pharmacol       Date:  2021-05-05       Impact factor: 3.716

5.  Global Fund financing and human resources for health investments in the Eastern Mediterranean Region.

Authors:  Adeyemi Okunogbe; Diana Bowser; Gulin Gedik; Saha Naseri; Ayat Abu-Agla; Najibullah Safi
Journal:  Hum Resour Health       Date:  2020-07-08

6.  Analysis of the Financing of Russian Health Care over the Past 100 Years.

Authors:  Vladimir Reshetnikov; Evgeny Arsentyev; Sergey Boljevic; Yuriy Timofeyev; Mihajlo Jakovljević
Journal:  Int J Environ Res Public Health       Date:  2019-05-24       Impact factor: 3.390

Review 7.  The development and reform of public health in China from 1949 to 2019.

Authors:  Li Wang; Zhihao Wang; Qinglian Ma; Guixia Fang; Jinxia Yang
Journal:  Global Health       Date:  2019-07-02       Impact factor: 4.185

8.  Editorial: NCDs - Core Challenge of Modern Day Health Care Establishments.

Authors:  Mihajlo Jakovljevic; Tarang Sharma; Narimasa Kumagai; Seiritsu Ogura
Journal:  Front Public Health       Date:  2021-06-18

9.  Real GDP growth rates and healthcare spending - comparison between the G7 and the EM7 countries.

Authors:  Mihajlo Jakovljevic; Yuriy Timofeyev; Chhabi Lal Ranabhat; Paula Odete Fernandes; João Paulo Teixeira; Nemanja Rancic; Vladimir Reshetnikov
Journal:  Global Health       Date:  2020-07-16       Impact factor: 4.185

10.  An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries.

Authors:  Kanykey Jailobaeva; Jennifer Falconer; Giulia Loffreda; Stella Arakelyan; Sophie Witter; Alastair Ager
Journal:  Global Health       Date:  2021-06-29       Impact factor: 4.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.